Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
Irina Petrache1, Joud Hajjar1, Michael Campos21Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA; 2Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Miller School of Medicine, University of Miami, Florida, USA Abstract: Alpha-1-a...
Guardado en:
Autores principales: | Irina Petrache, Joud Hajjar, Michael Campos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8716671a62674c23988e2a9f97cd9609 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
por: Dunlea DM, et al.
Publicado: (2018) -
Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives
por: Quinn M, et al.
Publicado: (2020) -
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
por: Caitriona McLean, et al.
Publicado: (2009) -
PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
por: M. Yu. Pervakova, et al.
Publicado: (2016) -
Evaluation of Alpha-1 antitrypsin level in the serum of children with idiopathic bronchiectasis
por: Maryam Babaei, et al.
Publicado: (2021)